SEC Tracker
Get the app

Replimune Group REPL

Xynos Konstantinos (Officer) plans to sell 15,881 REPL shares, about $119,185

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: Jun 7, 2024
  2. Broker: J.P. Morgan Securities LLC
  3. Shares acquired by: Rsetricted Stock Units
  4. 10b5-1 plan adopted: Feb 13, 2024

All of Xynos Konstantinos's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 15,881 shares at $7.5 on Jun 7, 2024 · Form 4

Written from the Form 144 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Replimune Group files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Heron Therapeutics HRTX public float $235M, Jun 30, 2025
  2. Aldeyra Therapeutics ALDX public float $232M, Jun 30, 2025
  3. Sagimet Biosciences SGMT public float $228M, Jun 30, 2025
  4. Annexon ANNX public float $244M, Jun 30, 2025
  5. Lifecore Biomedical LFCR public float $223M, Jun 30, 2025